28 Apr 2025 Research & Development Spotlight Series, Episode 9 Investors | R&D Spotlights Series | Therapeutics
28 Apr 2025 Avacta Therapeutics Presents Preclinical and Translational Data from pre|CISION® Platform Candidates at 2025 AACR Annual Meeting Investors | Therapeutics
28 Apr 2025 Avacta Therapeutics Presents Data from Lead pre|CISION® Candidate FAP-Dox (AVA6000) at the 2025 AACR Annual Meeting Investors | Therapeutics
31 Mar 2025 Avacta Provides Business Update for the First Quarter of 2025 Outlining Progress Against Strategic Objectives Investors